title: Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.
abstract: In a population-based case-control study, we explored the associations between 42 polymorphisms in seven genes in this region and non-small cell lung cancer (NSCLC) risk among Caucasian (364 cases; 380 controls) and African American (95 cases; 103 controls) women. Two TERT region SNPs, rs2075786 and rs2853677, conferred an increased risk of developing NSCLC, especially among African American women, and TERT-rs2735940 was associated with a decreased risk of lung cancer among African Americans. Five of the 20 GHR polymorphisms and SEPP1-rs6413428 were associated with a marginally increased risk of NSCLC among Caucasians. Random forest analysis reinforced the importance of GHR among Caucasians and identified AMACR, TERT, and GHR among African Americans, which were also significant using gene-based risk scores. Smoking-SNP interactions were explored, and haplotypes in TERT and GHR associated with NSCLC risk were identified. The roles of TERT, GHR, AMACR and SEPP1 genes in lung carcinogenesis warrant further exploration.
authors.affiliation: Cancer Biology Program, School of Medicine, Wayne State University, 4100 John R, Detroit, MI 48201, USA.
authors.forename: Alison L
authors.initials: AL
authors.lastname: Van Dyke
authors.forename: Michele L
authors.initials: ML
authors.lastname: Cote
authors.forename: Angela S
authors.initials: AS
authors.lastname: Wenzlaff
authors.forename: Judith
authors.initials: J
authors.lastname: Abrams
authors.forename: Susan
authors.initials: S
authors.lastname: Land
authors.forename: Priyanka
authors.initials: P
authors.lastname: Iyer
authors.forename: Ann G
authors.initials: AG
authors.lastname: Schwartz
references.citation: Jpn J Clin Oncol. 2008 Apr;38(4):308-16
references.pmid: 18299312
references.citation: Prostate. 2007 Oct 1;67(14):1507-13
references.pmid: 17683075
references.citation: Prostate. 2007 Oct 1;67(14):1487-97
references.pmid: 17680641
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1829-40
references.pmid: 19505916
references.citation: Mol Psychiatry. 2005 Apr;10(4):407-14
references.pmid: 15381926
references.citation: Lung Cancer. 2007 Apr;56(1):17-23
references.pmid: 17175058
references.citation: Biochem Biophys Res Commun. 1989 Jul 31;162(2):575-82
references.pmid: 2527031
references.citation: Lung Cancer. 2001 Nov;34(2):219-26
references.pmid: 11679180
references.citation: Lung Cancer. 2009 Jul;65(1):34-40
references.pmid: 19058871
references.citation: Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):252-5
references.pmid: 16082251
references.citation: J Med Genet. 2008 Oct;45(10):654-6
references.pmid: 18835860
references.citation: J Korean Med Sci. 2007 Sep;22 Suppl:S47-51
references.pmid: 17923754
references.citation: Eur J Surg Oncol. 2003 Sep;29(7):594-9
references.pmid: 12943625
references.citation: Health Psychol. 1999 Jan;18(1):7-13
references.pmid: 9925040
references.citation: Cancer Res. 2008 Dec 15;68(24):10171-7
references.pmid: 19074884
references.citation: Stat Med. 1996 Feb 28;15(4):361-87
references.pmid: 8668867
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1144-54
references.pmid: 18483336
references.citation: Genet Epidemiol. 2006 Sep;30(6):485-94
references.pmid: 16755519
references.citation: Bioessays. 2006 Feb;28(2):109-12
references.pmid: 16435298
references.citation: Pharmacogenetics. 1995 Jun;5(3):151-8
references.pmid: 7550366
references.citation: Lung Cancer. 2003 Aug;41(2):163-9
references.pmid: 12871779
references.citation: Environ Res. 1994 Apr;65(1):1-11
references.pmid: 8162876
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1285-91
references.pmid: 12433704
references.citation: J Clin Invest. 2008 Feb;118(2):640-50
references.pmid: 18172554
references.citation: Genome Res. 2001 May;11(5):863-74
references.pmid: 11337480
references.citation: Prostate. 2008 Sep 15;68(13):1373-9
references.pmid: 18537123
references.citation: Oncogene. 1998 Mar 5;16(9):1217-22
references.pmid: 9528864
references.citation: Am J Surg Pathol. 2002 Jul;26(7):926-31
references.pmid: 12131161
references.citation: Am J Hum Genet. 2007 Sep;81(3):559-75
references.pmid: 17701901
references.citation: Carcinogenesis. 2007 Aug;28(8):1718-25
references.pmid: 17468511
references.citation: Int J Cancer. 2006 Jun 1;118(11):2903-6
references.pmid: 16381017
references.citation: Br J Cancer. 2007 Sep 17;97(6):832-6
references.pmid: 17848914
references.citation: Pharmacogenet Genomics. 2005 Aug;15(8):547-55
references.pmid: 16006998
references.citation: Pharmacogenetics. 2003 Jun;13(6):339-47
references.pmid: 12777964
references.citation: MedGenMed. 2004 Jul 26;6(3):19
references.pmid: 15520642
references.citation: Nat Genet. 2009 Feb;41(2):221-7
references.pmid: 19151717
references.citation: Nat Genet. 2008 Dec;40(12):1407-9
references.pmid: 18978787
references.citation: Arch Pathol Lab Med. 2007 Oct;131(10):1555-60
references.pmid: 17922592
references.citation: Genome Res. 2006 Jun;16(6):693-701
references.pmid: 16741161